Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2007, Vol. 12 ›› Issue (2): 204-207.

Previous Articles     Next Articles

Estimation of sample size in individual bioequivalence

LU Jing-jing1, CHEN Feng2, CUI Yong-chun3, WANG Shou-cang1, ZHANG Ai-min1, LI Ren-peng1, XU Jin-ke1   

  1. 1CDC of Shandong province, Jinan 250014, Shandong, China;
    2Department of Epidemiology and Biostatistics, Nanjing Medical University, Nanjing 210029, Jiangsu, China;
    3Shandong Provincial Tumor Hospital, Jinan 250117, Shandong, China
  • Received:2006-09-02 Revised:2006-10-30 Online:2007-02-26 Published:2020-10-27

Abstract: AIM: To compare efficacy of two designs and three test approaches in individual bioequivalence and estimate sample size.METHODS: Monte-Carlo simulation research was applied.RESULTS: Sample size under 2×4 cross-over design is less than that under 2×3 crossover design.When, estimation method is feasible in estimating sample size.Whereas is close to 0.2,we can use test method to determine sample size.Then, either method is chosen to determine sample size.Consequently, we are able to choose appropriate method to estimate sample size.CONCLUSION: Sample size of individual bioequivalence is different as σWR, σD and designs are changed.

Key words: individual bioequivalence, sample size, efficacy

CLC Number: